SB271 amends Title 18 of the Delaware Code to establish new regulatory requirements for pharmacy benefits managers operating within Delaware. The legislation modifies how PBMs conduct business in the state, potentially affecting reimbursement structures, transparency requirements, and relationships between PBMs, insurers, and healthcare providers. Specific provisions address PBM licensing, oversight, and consumer protections.

Pharmacy benefits managers, health insurers, and healthcare providers operating in Delaware should review their current contracts and operational practices to ensure compliance with the new requirements under Title 18. Entities should consult with Delaware regulatory agencies for implementation guidance and any associated compliance timelines. Failure to comply may result in regulatory enforcement under Delaware insurance law.